Startseite
Reels
Gruppen
Seiten
Mehr sehen
Gruppen Seiten Veranstaltungen Blogs Spendenaufruf
Anmelden Registrieren
Nachtmodus
Triple-Negative Breast Cancer: The Frontline of Innovation in HER2 Negative Disease
Within the HER2 negative breast cancer category, triple-negative breast cancer (TNBC) stands out as the most aggressive and historically most challenging subtype. Lacking estrogen receptors, progesterone receptors, and HER2 expression, TNBC doesn't respond to targeted therapies that benefit other breast cancer types, leaving chemotherapy as the mainstay for decades. That's changing...
0 Kommentare ·0 Geteilt ·13 Ansichten ·0 Bewertungen
Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!